| Melanie Pelletier, MS FNP-C | |
|
2720 Sunset Blvd, West Columbia, SC 29169-4810 | |
| (803) 791-2000 | |
| Not Available |
| Full Name | Melanie Pelletier |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2720 Sunset Blvd, West Columbia, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831529650 | NPI | - | NPPES |
| Provider Name | Lexington Health Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1710634753 PECOS PAC ID: 2567872070 Enrollment ID: O20201208000922 |
News Archive
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the expansion of its microRNA (miRNA) product line with a multiplexed assay for profiling the mouse miRNA transcriptome.
Lifestyle and health factors that are good for your heart can also prevent diabetes, according to a new study by researchers at The Ohio State University Wexner Medical Center and College of Medicine that published today in Diabetologia, the journal of the European Association for the Study of Diabetes.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.
An article published today in the Annals of Internal Medicine reports that 25 million dwellings that house 81 million Americans lack adequate space or plumbing to allow compliance with recommendations that a person who may have COVID-19 maintain physical separation from others in their household.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Melanie Pelletier, MS FNP-C Po Box 6069, West Columbia, SC 29171-6069 Ph: (803) 935-8292 | Melanie Pelletier, MS FNP-C 2720 Sunset Blvd, West Columbia, SC 29169-4810 Ph: (803) 791-2000 |
News Archive
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the expansion of its microRNA (miRNA) product line with a multiplexed assay for profiling the mouse miRNA transcriptome.
Lifestyle and health factors that are good for your heart can also prevent diabetes, according to a new study by researchers at The Ohio State University Wexner Medical Center and College of Medicine that published today in Diabetologia, the journal of the European Association for the Study of Diabetes.
Goodwin Biotechnology, Inc., a biological Contract Development and Manufacturing Organization that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing Mammalian Cell Culture expression systems and Bioconjugation technologies, was selected by Panacea Pharmaceuticals, Inc. to complete a novel Fill / Finish project, as well as Quality Control release and stability testing for a therapeutic, nanoparticle cancer vaccine based on the Human Aspartyl (Asparaginyl) β-Hydroxylase (HAAH) tumor-specific protein to support Phase I clinical trials in patients with various solid tumor cancers.
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.
An article published today in the Annals of Internal Medicine reports that 25 million dwellings that house 81 million Americans lack adequate space or plumbing to allow compliance with recommendations that a person who may have COVID-19 maintain physical separation from others in their household.
› Verified 1 days ago